文献速递急性肾损伤血液净化与透析

Brophy套件:用于新生儿的手动血液透析装置

The Brophy Kit: A Manual Hemodialysis Device for Neonates.
PubMed 文献 · Kidney Int Rep · 2024-11-25

本研究将Kirpa套件手动透析装置小型化为Brophy套件,并在体外评估其清除和超滤性能。采用稀释红细胞进行12次清除和3次超滤实验,结果显示30个清除循环后BUN和钾中位降低分别为31.0%和35.0%,60个超滤循环后血细胞比容中位升至52.6%。Brophy套件可能弥补小新生儿肾脏替代治疗的技术空白。

要点

  • Brophy套件在体外能有效清除BUN和钾,并稳定超滤。
  • 该装置体外循环血量小,且可单腔通路运行,适合小体重新生儿。
  • 现有KRT设备仅适用于体重≥2.5 kg且需双腔或两根单腔导管。

核心结论

  • Brophy套件在体外清除效率高且超滤性能稳定。
  • 该装置因体外血量小和可单腔通路运行,可能弥补小新生儿KRT技术空白。

研究设计与样本

  • 将Kirpa套件手动透析装置小型化为Brophy套件,并进行体外清除和超滤性能评估。
  • 使用稀释至正常血细胞比容(31.1%-36.8%)的浓缩红细胞,进行12次清除实验和3次超滤实验。

主要发现

  • 30个清除循环后,BUN中位降低31.0%(IQR 17.6-37.9),钾中位降低35.0%(IQR 26.9-41.7)。
  • 60个超滤循环后,血细胞比容中位升至52.6%(IQR 52.5-53.8),高于预期值47.7%。

临床怎么用

  • Brophy套件可能用于需要肾脏替代治疗的小体重新生儿,尤其是现有设备不适用的低体重儿。

局限性

  • 研究为体外实验,未在临床患者中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Acute kidney injury (AKI) is common in critically ill neonates, including very and extremely low birth weight (VLBW, ELBW) neonates. In severe cases, kidney replacement therapy (KRT) may be warranted. Currently, available KRT devices are only indicated for those weighing ≥ 2.5 kg and require a double lumen or 2 separate single lumen catheters. We miniaturized the Kirpa Kit manual dialysis device, naming it the Brophy Kit, and we assessed its in vitro clearance and ultrafiltration (UF) performance. METHODS: We diluted packed red blood cells to a normal hematocrit (Hct: 31.1%-36.8%) and conducted 12 clearance and 3 UF experiments. A cycle consisted of aspirating 10 ml of blood from the blood bag, passing it through a hemofilter, and returning it in a circular path. For clearance experiments, we tested 4 configurations, with varied timing and volume of saline flushes to refresh the dialysis compartment, then measured blood urea nitrogen (BUN) and potassium concentrations every 5 cycles. For each UF cycle, 1 ml of ultrafiltrate was removed, and Hct was measured every 10 cycles. RESULTS: Median BUN and potassium reduction were 31.0% (interquartile range [IQR]: 17.6-37.9) and 35.0% (IQR: 26.9-41.7), respectively, after 30 clearance cycles. Median Hct increased to 52.6% (IQR: 52.5-53.8) after 60 UF cycles, more than the expected Hct (47.7%). CONCLUSION: The Brophy Kit performs in vitro clearance efficiently and UF consistently. The Brophy Kit may address a technological KRT gap for small neonates because of its minimal extracorporeal volume and ability to function with single lumen access.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ceschia G, Slagle CL, Morgan J, et al. The Brophy Kit: A Manual Hemodialysis Device for Neonates. Kidney Int Rep. 2024. PMID: 39990882. doi:10.1016/j.ekir.2024.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。